Market Snapshot
CAGR:8.84
Study Period |
2019-2032 |
Base Year |
2023 |
Forcast Year |
2023-2032 |
CAGR |
8.84 |
Report Overview
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
The global Short Bowel Syndrome market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2019-2026. The objectives of this study are to define, segment, and project the size of the Short Bowel Syndrome market based on company, product type, end user and key regions.
This report studies the global market size of Short Bowel Syndrome in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Short Bowel Syndrome in these regions.
This research report categorizes the global Short Bowel Syndrome market by top players/brands, region, type and end user. This report also studies the global Short Bowel Syndrome market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shire
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Market size by Product
GLP-2
Growth Hormone
Glutamine
Others
Market size by End User
Hospitals
Clinics
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Short Bowel Syndrome market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2026.
To understand the structure of Short Bowel Syndrome market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Short Bowel Syndrome companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Short Bowel Syndrome submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Short Bowel Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Short Bowel Syndrome market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Short Bowel Syndrome Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Short Bowel Syndrome Market Size Growth Rate by Product
1.4.2 GLP-2
1.4.3 Growth Hormone
1.4.4 Glutamine
1.4.5 Others
1.5 Market by End User
1.5.1 Global Short Bowel Syndrome Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Short Bowel Syndrome Market Size
2.1.1 Global Short Bowel Syndrome Revenue 2014-2025
2.1.2 Global Short Bowel Syndrome Sales 2014-2025
2.2 Short Bowel Syndrome Growth Rate by Regions
2.2.1 Global Short Bowel Syndrome Sales by Regions
2.2.2 Global Short Bowel Syndrome Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Short Bowel Syndrome Sales by Manufacturers
3.1.1 Short Bowel Syndrome Sales by Manufacturers
3.1.2 Short Bowel Syndrome Sales Market Share by Manufacturers
3.1.3 Global Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Short Bowel Syndrome Revenue by Manufacturers
3.2.1 Short Bowel Syndrome Revenue by Manufacturers (2014-2019)
3.2.2 Short Bowel Syndrome Revenue Share by Manufacturers (2014-2019)
3.3 Short Bowel Syndrome Price by Manufacturers
3.4 Short Bowel Syndrome Manufacturing Base Distribution, Product Types
3.4.1 Short Bowel Syndrome Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Short Bowel Syndrome Product Type
3.4.3 Date of International Manufacturers Enter into Short Bowel Syndrome Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Short Bowel Syndrome Sales by Product
4.2 Global Short Bowel Syndrome Revenue by Product
4.3 Short Bowel Syndrome Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Short Bowel Syndrome Breakdown Data by End User
6 North America
6.1 North America Short Bowel Syndrome by Countries
6.1.1 North America Short Bowel Syndrome Sales by Countries
6.1.2 North America Short Bowel Syndrome Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Short Bowel Syndrome by Product
6.3 North America Short Bowel Syndrome by End User
7 Europe
7.1 Europe Short Bowel Syndrome by Countries
7.1.1 Europe Short Bowel Syndrome Sales by Countries
7.1.2 Europe Short Bowel Syndrome Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Short Bowel Syndrome by Product
7.3 Europe Short Bowel Syndrome by End User
8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome by Countries
8.1.1 Asia Pacific Short Bowel Syndrome Sales by Countries
8.1.2 Asia Pacific Short Bowel Syndrome Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Short Bowel Syndrome by Product
8.3 Asia Pacific Short Bowel Syndrome by End User
9 Central & South America
9.1 Central & South America Short Bowel Syndrome by Countries
9.1.1 Central & South America Short Bowel Syndrome Sales by Countries
9.1.2 Central & South America Short Bowel Syndrome Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Short Bowel Syndrome by Product
9.3 Central & South America Short Bowel Syndrome by End User
10 Middle East and Africa
10.1 Middle East and Africa Short Bowel Syndrome by Countries
10.1.1 Middle East and Africa Short Bowel Syndrome Sales by Countries
10.1.2 Middle East and Africa Short Bowel Syndrome Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Short Bowel Syndrome by Product
10.3 Middle East and Africa Short Bowel Syndrome by End User
11 Company Profiles
11.1 Shire
11.1.1 Shire Company Details
11.1.2 Company Business Overview
11.1.3 Shire Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Shire Short Bowel Syndrome Products Offered
11.1.5 Shire Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Short Bowel Syndrome Products Offered
11.2.5 Merck Recent Development
11.3 Emmaus Life Sciences
11.3.1 Emmaus Life Sciences Company Details
11.3.2 Company Business Overview
11.3.3 Emmaus Life Sciences Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Emmaus Life Sciences Short Bowel Syndrome Products Offered
11.3.5 Emmaus Life Sciences Recent Development
11.4 Nutrinia
11.4.1 Nutrinia Company Details
11.4.2 Company Business Overview
11.4.3 Nutrinia Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Nutrinia Short Bowel Syndrome Products Offered
11.4.5 Nutrinia Recent Development
11.5 GlyPharma Therapeutics
11.5.1 GlyPharma Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 GlyPharma Therapeutics Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlyPharma Therapeutics Short Bowel Syndrome Products Offered
11.5.5 GlyPharma Therapeutics Recent Development
11.6 OxThera
11.6.1 OxThera Company Details
11.6.2 Company Business Overview
11.6.3 OxThera Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.6.4 OxThera Short Bowel Syndrome Products Offered
11.6.5 OxThera Recent Development
11.7 Ardelyx
11.7.1 Ardelyx Company Details
11.7.2 Company Business Overview
11.7.3 Ardelyx Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Ardelyx Short Bowel Syndrome Products Offered
11.7.5 Ardelyx Recent Development
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Details
11.8.2 Company Business Overview
11.8.3 Sancilio & Company Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sancilio & Company Short Bowel Syndrome Products Offered
11.8.5 Sancilio & Company Recent Development
11.9 Naia Pharmaceuticals
11.9.1 Naia Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Naia Pharmaceuticals Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Naia Pharmaceuticals Short Bowel Syndrome Products Offered
11.9.5 Naia Pharmaceuticals Recent Development
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Zealand Pharma Short Bowel Syndrome Products Offered
11.10.5 Zealand Pharma Recent Development
12 Future Forecast
12.1 Short Bowel Syndrome Market Forecast by Regions
12.1.1 Global Short Bowel Syndrome Sales Forecast by Regions 2019-2025
12.1.2 Global Short Bowel Syndrome Revenue Forecast by Regions 2019-2025
12.2 Short Bowel Syndrome Market Forecast by Product
12.2.1 Global Short Bowel Syndrome Sales Forecast by Product 2019-2025
12.2.2 Global Short Bowel Syndrome Revenue Forecast by Product 2019-2025
12.3 Short Bowel Syndrome Market Forecast by End User
12.4 North America Short Bowel Syndrome Forecast
12.5 Europe Short Bowel Syndrome Forecast
12.6 Asia Pacific Short Bowel Syndrome Forecast
12.7 Central & South America Short Bowel Syndrome Forecast
12.8 Middle East and Africa Short Bowel Syndrome Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Short Bowel Syndrome Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Short Bowel Syndrome Product Picture
Table Short Bowel Syndrome Market Segments
Table Key Manufacturers Short Bowel Syndrome Covered
Table Global Short Bowel Syndrome Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Short Bowel Syndrome Sales Market Share by Product 2014-2025
Figure GLP-2 Product Picture
Table Major Manufacturers of GLP-2
Figure Growth Hormone Product Picture
Table Major Manufacturers of Growth Hormone
Figure Glutamine Product Picture
Table Major Manufacturers of Glutamine
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Short Bowel Syndrome Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Short Bowel Syndrome Report Years Considered
Figure Global Short Bowel Syndrome Market Size 2014-2025 (Million US$)
Figure Global Short Bowel Syndrome Sales 2014-2025 (K Units)
Table Global Short Bowel Syndrome Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Short Bowel Syndrome Sales by Regions 2014-2019 (K Units)
Table Global Short Bowel Syndrome Sales Market Share by Regions 2014-2019
Figure Global Short Bowel Syndrome Sales Market Share by Regions 2014-2019
Figure 2018 Global Short Bowel Syndrome Sales Market Share by Regions
Table Global Short Bowel Syndrome Revenue by Regions 2014-2019 (Million US$)
Table Global Short Bowel Syndrome Revenue Market Share by Regions 2014-2019
Figure Global Short Bowel Syndrome Revenue Market Share by Regions 2014-2019
Figure 2018 Global Short Bowel Syndrome Revenue Market Share by Regions
Table Global Short Bowel Syndrome Sales by Manufacturers (2014-2019) (K Units)
Table Global Short Bowel Syndrome Sales Share by Manufacturers (2014-2019)
Figure Global Short Bowel Syndrome Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Short Bowel Syndrome Revenue by Manufacturers (2014-2019) (Million USD)
Table Short Bowel Syndrome Revenue Share by Manufacturers (2014-2019)
Figure Short Bowel Syndrome Value Share by Manufacturers in 2018
Table Key Manufacturers Short Bowel Syndrome Price (2014-2019) (USD/Unit)
Table Short Bowel Syndrome Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Short Bowel Syndrome Product Type
Table Date of International Manufacturers Enter into Short Bowel Syndrome Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Short Bowel Syndrome Sales by Product (2014-2019) (K Units)
Table Global Short Bowel Syndrome Sales Share by Product (2014-2019)
Figure Global Short Bowel Syndrome Sales Market Share by Product (2014-2019)
Figure Global Short Bowel Syndrome Sales Market Share by Product in 2018
Table Global Short Bowel Syndrome Revenue by Product (2014-2019) (Million US$)
Table Global Short Bowel Syndrome Revenue Share by Product (2014-2019)
Figure Global Short Bowel Syndrome Revenue Market Share by Product (2014-2019)
Figure Global Short Bowel Syndrome Revenue Market Share by Product in 2018
Table Short Bowel Syndrome Price by Product 2014-2019 (USD/Unit)
Table Global Short Bowel Syndrome Sales by End User (2014-2019) (K Units)
Table Global Short Bowel Syndrome Sales Share by End User (2014-2019)
Figure Global Sales Short Bowel Syndrome Market Share by End User (2014-2019)
Figure Global Sales Short Bowel Syndrome Market Share by End User in 2018
Figure North America Short Bowel Syndrome Sales Growth Rate 2014-2019 (K Units)
Figure North America Short Bowel Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table North America Short Bowel Syndrome Sales by Countries (2014-2019) (K Units)
Table North America Short Bowel Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 North America Short Bowel Syndrome Sales Market Share by Countries
Table North America Short Bowel Syndrome Revenue by Countries (2014-2019) (Million US$)
Table North America Short Bowel Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Short Bowel Syndrome Revenue Market Share by Countries
Figure United States Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure United States Short Bowel Syndrome Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Canada Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table North America Short Bowel Syndrome Sales by Product (2014-2019) (K Units)
Table North America Short Bowel Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 North America Short Bowel Syndrome Market Share by Product
Table North America Short Bowel Syndrome Sales by End User (2014-2019) (K Units)
Table North America Short Bowel Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 North America Short Bowel Syndrome Market Share by End User
Figure Europe Short Bowel Syndrome Sales Growth Rate 2014-2019 (K Units)
Figure Europe Short Bowel Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Short Bowel Syndrome Sales by Countries (2014-2019) (K Units)
Table Europe Short Bowel Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Short Bowel Syndrome Sales Market Share by Countries
Table Europe Short Bowel Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Europe Short Bowel Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Short Bowel Syndrome Revenue Market Share by Countries
Figure Germany Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Germany Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure France Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure France Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure UK Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Italy Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Russia Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Short Bowel Syndrome Sales by Product (2014-2019) (K Units)
Table Europe Short Bowel Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Europe Short Bowel Syndrome Market Share by Product
Table Europe Short Bowel Syndrome Sales by End User (2014-2019) (K Units)
Table Europe Short Bowel Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Europe Short Bowel Syndrome Market Share by End User
Figure Asia Pacific Short Bowel Syndrome Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Short Bowel Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Short Bowel Syndrome Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Short Bowel Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Short Bowel Syndrome Sales Market Share by Countries
Table Asia Pacific Short Bowel Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Short Bowel Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Short Bowel Syndrome Revenue Market Share by Countries
Figure China Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure China Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Japan Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Korea Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure India Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure India Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Australia Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Short Bowel Syndrome Sales by Product (2014-2019) (K Units)
Table Asia Pacific Short Bowel Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Short Bowel Syndrome Market Share by Product
Table Asia Pacific Short Bowel Syndrome Sales by End User (2014-2019) (K Units)
Table Asia Pacific Short Bowel Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Short Bowel Syndrome Market Share by End User
Figure Central & South America Short Bowel Syndrome Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Short Bowel Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Short Bowel Syndrome Sales by Countries (2014-2019) (K Units)
Table Central & South America Short Bowel Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Short Bowel Syndrome Sales Market Share by Countries
Table Central & South America Short Bowel Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Short Bowel Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Short Bowel Syndrome Revenue Market Share by Countries
Figure Brazil Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Short Bowel Syndrome Sales by Product (2014-2019) (K Units)
Table Central & South America Short Bowel Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Short Bowel Syndrome Market Share by Product
Table Central & South America Short Bowel Syndrome Sales by End User (2014-2019) (K Units)
Table Central & South America Short Bowel Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Short Bowel Syndrome Market Share by End User
Figure Middle East and Africa Short Bowel Syndrome Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Short Bowel Syndrome Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Short Bowel Syndrome Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Short Bowel Syndrome Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Short Bowel Syndrome Sales Market Share by Countries
Table Middle East and Africa Short Bowel Syndrome Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Short Bowel Syndrome Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Short Bowel Syndrome Revenue Market Share by Countries
Figure GCC Countries Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Short Bowel Syndrome Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Short Bowel Syndrome Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Short Bowel Syndrome Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Short Bowel Syndrome Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Short Bowel Syndrome Market Share by Product
Table Middle East and Africa Short Bowel Syndrome Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Short Bowel Syndrome Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Short Bowel Syndrome Market Share by End User
Table Shire Company Details
Table Shire Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Recent Development
Table Merck Company Details
Table Merck Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Emmaus Life Sciences Company Details
Table Emmaus Life Sciences Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Emmaus Life Sciences Recent Development
Table Nutrinia Company Details
Table Nutrinia Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nutrinia Recent Development
Table GlyPharma Therapeutics Company Details
Table GlyPharma Therapeutics Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlyPharma Therapeutics Recent Development
Table OxThera Company Details
Table OxThera Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table OxThera Recent Development
Table Ardelyx Company Details
Table Ardelyx Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ardelyx Recent Development
Table Sancilio & Company Company Details
Table Sancilio & Company Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sancilio & Company Recent Development
Table Naia Pharmaceuticals Company Details
Table Naia Pharmaceuticals Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Naia Pharmaceuticals Recent Development
Table Zealand Pharma Company Details
Table Zealand Pharma Short Bowel Syndrome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zealand Pharma Recent Development
Table Global Short Bowel Syndrome Sales Forecast by Regions 2019-2025 (K Units)
Table Global Short Bowel Syndrome Sales Market Share Forecast by Regions 2019-2025
Table Global Short Bowel Syndrome Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Short Bowel Syndrome Revenue Market Share Forecast by Regions 2019-2025
Table Global Short Bowel Syndrome Sales Forecast by Product 2019-2025 (K Units)
Table Global Short Bowel Syndrome Sales Market Share Forecast by Product 2019-2025
Table Global Short Bowel Syndrome Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Short Bowel Syndrome Revenue Market Share Forecast by Product 2019-2025
Table Global Short Bowel Syndrome Sales Forecast by End User 2019-2025 (K Units)
Table Global Short Bowel Syndrome Sales Market Share Forecast by End User 2019-2025
Figure North America Short Bowel Syndrome Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Short Bowel Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Short Bowel Syndrome Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Short Bowel Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Short Bowel Syndrome Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Short Bowel Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Short Bowel Syndrome Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Short Bowel Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Short Bowel Syndrome Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Short Bowel Syndrome Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Short Bowel Syndrome Value Chain
Table Short Bowel Syndrome Customers List
Table Short Bowel Syndrome Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now letās take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.